Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4101712
Max Phase: Preclinical
Molecular Formula: C42H60N6O17S
Molecular Weight: 953.03
Molecule Type: Small molecule
Associated Items:
ID: ALA4101712
Max Phase: Preclinical
Molecular Formula: C42H60N6O17S
Molecular Weight: 953.03
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CSCC[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N1C[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@@H](CO)[C@@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@H]2O)C[C@H]1C(N)=O
Standard InChI: InChI=1S/C42H60N6O17S/c1-66-12-11-25(47-38(59)24(43)13-21-7-9-22(51)10-8-21)39(60)45-16-30(52)46-26(14-20-5-3-2-4-6-20)40(61)48-17-23(15-27(48)37(44)58)62-41-35(57)33(55)36(29(19-50)64-41)65-42-34(56)32(54)31(53)28(18-49)63-42/h2-10,23-29,31-36,41-42,49-51,53-57H,11-19,43H2,1H3,(H2,44,58)(H,45,60)(H,46,52)(H,47,59)/t23-,24-,25+,26-,27-,28-,29+,31+,32+,33+,34-,35+,36+,41+,42+/m0/s1
Standard InChI Key: LDKMYXVTHNNGBM-PPYJAVFUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 953.03 | Molecular Weight (Monoisotopic): 952.3736 | AlogP: -5.56 | #Rotatable Bonds: 21 |
Polar Surface Area: 375.48 | Molecular Species: NEUTRAL | HBA: 19 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 15 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.51 | CX Basic pKa: 7.73 | CX LogP: -5.00 | CX LogD: -5.36 |
Aromatic Rings: 2 | Heavy Atoms: 66 | QED Weighted: 0.06 | Np Likeness Score: 0.55 |
1. Rosa M, Gonzalez-Nunez V, Barreto-Valer K, Marcelo F, Sánchez-Sánchez J, Calle LP, Arévalo JC, Rodríguez RE, Jiménez-Barbero J, Arsequell G, Valencia G.. (2017) Role of the sugar moiety on the opioid receptor binding and conformation of a series of enkephalin neoglycopeptides., 25 (7): [PMID:28284867] [10.1016/j.bmc.2017.02.052] |
Source(1):